• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化的犬和小鼠间充质干细胞作为具有复杂基因组学的肉瘤模型。

Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics.

作者信息

Franceschini Natasja, Verbruggen Bas, Tryfonidou Marianna A, Kruisselbrink Alwine B, Baelde Hans, de Visser Karin E, Szuhai Karoly, Cleton-Jansen Anne-Marie, Bovée Judith V M G

机构信息

Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands.

出版信息

Cancers (Basel). 2021 Mar 5;13(5):1126. doi: 10.3390/cancers13051126.

DOI:10.3390/cancers13051126
PMID:33807947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961539/
Abstract

Sarcomas are rare mesenchymal tumors with a broad histological spectrum, but they can be divided into two groups based on molecular pathology: sarcomas with simple or complex genomics. Tumors with complex genomics can have aneuploidy and copy number gains and losses, which hampers the detection of early, initiating events in tumorigenesis. Often, no benign precursors are known, which is why good models are essential. The mesenchymal stem cell (MSC) is the presumed cell of origin of sarcoma. In this study, MSCs of murine and canine origin are used as a model to identify driver events for sarcomas with complex genomic alterations as they transform spontaneously after long-term culture. All transformed murine but not canine MSCs formed sarcomas after subcutaneous injection in mice. Using whole genome sequencing, spontaneously transformed murine and canine MSCs displayed a complex karyotype with aneuploidy, point mutations, structural variants, inter-chromosomal translocations, and copy number gains and losses. Cross-species analysis revealed that point mutations in are common in transformed murine and canine MSCs. Murine MSCs with a cre-recombinase induced deletion of exon 2-10 of transformed earlier compared to wild-type murine MSCs, confirming the contribution of loss of p53 to spontaneous transformation. Our comparative approach using transformed murine and canine MSCs points to a crucial role for p53 loss in the formation of sarcomas with complex genomics.

摘要

肉瘤是罕见的间充质肿瘤,具有广泛的组织学谱,但根据分子病理学可分为两组:基因组简单或复杂的肉瘤。基因组复杂的肿瘤可出现非整倍体以及拷贝数的增加和减少,这会妨碍对肿瘤发生早期起始事件的检测。通常,尚无已知的良性前体,这就是良好模型至关重要的原因。间充质干细胞(MSC)被认为是肉瘤的起源细胞。在本研究中,将源自小鼠和犬的MSC用作模型,以鉴定基因组改变复杂的肉瘤的驱动事件,因为它们在长期培养后会自发转化。所有转化的小鼠MSC(但不是犬MSC)在皮下注射到小鼠体内后都会形成肉瘤。通过全基因组测序,自发转化的小鼠和犬MSC显示出具有非整倍体、点突变、结构变异、染色体间易位以及拷贝数增加和减少的复杂核型。跨物种分析表明,[此处原文缺失具体基因名称]中的点突变在转化的小鼠和犬MSC中很常见。与野生型小鼠MSC相比,具有cre重组酶诱导的[此处原文缺失具体基因名称]外显子2 - 10缺失的小鼠MSC转化得更早,证实了p53缺失对自发转化的作用。我们使用转化的小鼠和犬MSC的比较方法表明p53缺失在基因组复杂的肉瘤形成中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/c50c8c2199c7/cancers-13-01126-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/4899e230b971/cancers-13-01126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/84663e89bc38/cancers-13-01126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/14c8676d849c/cancers-13-01126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/455bda0efe92/cancers-13-01126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/dc4502c08b10/cancers-13-01126-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/c50c8c2199c7/cancers-13-01126-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/4899e230b971/cancers-13-01126-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/84663e89bc38/cancers-13-01126-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/14c8676d849c/cancers-13-01126-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/455bda0efe92/cancers-13-01126-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/dc4502c08b10/cancers-13-01126-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7961539/c50c8c2199c7/cancers-13-01126-g006.jpg

相似文献

1
Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics.转化的犬和小鼠间充质干细胞作为具有复杂基因组学的肉瘤模型。
Cancers (Basel). 2021 Mar 5;13(5):1126. doi: 10.3390/cancers13051126.
2
A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target.一个用于引发骨肉瘤发生事件的鼠间充质干细胞模型表明 CDK4/CDK6 抑制是一种治疗靶点。
Lab Invest. 2022 Apr;102(4):391-400. doi: 10.1038/s41374-021-00709-z. Epub 2021 Dec 17.
3
Mesenchymal stem cell transformation and sarcoma genesis.间充质干细胞转化与肉瘤发生。
Clin Sarcoma Res. 2013 Jul 23;3(1):10. doi: 10.1186/2045-3329-3-10.
4
The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.p53-Rb 缺陷型骨髓间充质干细胞的分化阶段赋予体内肉瘤发展的表型。
Oncogene. 2013 Oct 10;32(41):4970-80. doi: 10.1038/onc.2012.507. Epub 2012 Dec 10.
5
Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.p53 缺失而非视网膜母细胞瘤导致间充质干细胞在体外转化,并在体内引发平滑肌肉瘤。
Cancer Res. 2010 May 15;70(10):4185-94. doi: 10.1158/0008-5472.CAN-09-4640. Epub 2010 May 4.
6
Loss of interactions between p53 and survivin gene in mesenchymal stem cells after spontaneous transformation in vitro.体外自发转化后间充质干细胞中p53与生存素基因间相互作用的丧失
Int J Biochem Cell Biol. 2016 Jun;75:74-84. doi: 10.1016/j.biocel.2016.03.018. Epub 2016 Mar 30.
7
Mesenchymal loss of p53 alters stem cell capacity and models human soft tissue sarcoma traits.间质 p53 的缺失改变了干细胞的能力,并模拟了人类软组织肉瘤的特征。
Stem Cell Reports. 2023 May 9;18(5):1211-1226. doi: 10.1016/j.stemcr.2023.03.009. Epub 2023 Apr 13.
8
Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.骨肉瘤起源于间充质干细胞,是由于非整倍体和 Cdkn2 的基因组缺失所致。
J Pathol. 2009 Nov;219(3):294-305. doi: 10.1002/path.2603.
9
A novel rat fibrosarcoma cell line from transformed bone marrow-derived mesenchymal stem cells with maintained in vitro and in vivo stemness properties.一种源自转化的骨髓间充质干细胞的新型大鼠纤维肉瘤细胞系,具有体外和体内维持的干性特性。
Exp Cell Res. 2017 Mar 15;352(2):218-224. doi: 10.1016/j.yexcr.2017.02.005. Epub 2017 Feb 9.
10
A porcine model of osteosarcoma.骨肉瘤的猪模型。
Oncogenesis. 2016 Mar 14;5(3):e210. doi: 10.1038/oncsis.2016.19.

引用本文的文献

1
Craniomaxillofacial-Derived MSCs in Congenital Defect Reconstruction.用于先天性缺陷重建的颅颌面来源间充质干细胞
Biomolecules. 2025 Jun 30;15(7):953. doi: 10.3390/biom15070953.
2
Role of proteoglycan synthesis genes in osteosarcoma stem cells.蛋白聚糖合成基因在骨肉瘤干细胞中的作用。
Front Oncol. 2024 Apr 16;14:1325794. doi: 10.3389/fonc.2024.1325794. eCollection 2024.
3
Clinical, pathologic and molecular findings in 2 Rottweiler littermates with appendicular osteosarcoma.2只患有附肢骨肉瘤的罗威纳犬同窝幼犬的临床、病理和分子学发现

本文引用的文献

1
The lower in vitro chondrogenic potential of canine adipose tissue-derived mesenchymal stromal cells (MSC) compared to bone marrow-derived MSC is not improved by BMP-2 or BMP-6.与骨髓来源的间充质基质细胞(MSC)相比,犬脂肪组织来源的MSC较低的体外软骨形成潜能不会因骨形态发生蛋白-2(BMP-2)或骨形态发生蛋白-6(BMP-6)而得到改善。
Vet J. 2021 Mar;269:105605. doi: 10.1016/j.tvjl.2020.105605. Epub 2020 Dec 29.
2
p53: 800 million years of evolution and 40 years of discovery.p53:8 亿年的进化与 40 年的发现。
Nat Rev Cancer. 2020 Aug;20(8):471-480. doi: 10.1038/s41568-020-0262-1. Epub 2020 May 13.
3
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Res Sq. 2024 Apr 11:rs.3.rs-4223759. doi: 10.21203/rs.3.rs-4223759/v1.
4
Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.骨肉瘤干细胞化疗耐药中的自我更新和多能性:Notch、Hedgehog 和 Wnt/β-catenin 与胚胎标志物的相互作用。
Int J Mol Sci. 2023 May 7;24(9):8401. doi: 10.3390/ijms24098401.
5
The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells.c-Myc/TBX3轴促进肉瘤起始细胞的细胞转化。
Front Oncol. 2022 Jan 25;11:801691. doi: 10.3389/fonc.2021.801691. eCollection 2021.
6
Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression.靶向 NAD 补救合成途径作为低 NAPRT 表达骨肉瘤的新型治疗策略。
Int J Mol Sci. 2021 Jun 10;22(12):6273. doi: 10.3390/ijms22126273.
利用全基因组测序技术对 2658 个人类癌症中的染色体重排进行全面分析。
Nat Genet. 2020 Mar;52(3):331-341. doi: 10.1038/s41588-019-0576-7. Epub 2020 Feb 5.
4
What's new in bone forming tumours of the skeleton?骨骼形成肿瘤有哪些新进展?
Virchows Arch. 2020 Jan;476(1):147-157. doi: 10.1007/s00428-019-02683-w. Epub 2019 Nov 18.
5
Canine osteosarcoma genome sequencing identifies recurrent mutations in and the histone methyltransferase gene .犬骨肉瘤基因组测序鉴定出 和组蛋白甲基转移酶基因 的反复突变。
Commun Biol. 2019 Jul 19;2:266. doi: 10.1038/s42003-019-0487-2. eCollection 2019.
6
Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing.通过靶向下一代测序鉴定出切除复发性未分化多形性肉瘤中的致病性和可靶向遗传改变。
Cancer Genomics Proteomics. 2019 May-Jun;16(3):221-228. doi: 10.21873/cgp.20127.
7
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways.未分化肉瘤通过不同的进化途径发展。
Cancer Cell. 2019 Mar 18;35(3):441-456.e8. doi: 10.1016/j.ccell.2019.02.002.
8
Molecular Pathology of Bone Tumors.骨肿瘤的分子病理学
J Mol Diagn. 2019 Mar;21(2):171-182. doi: 10.1016/j.jmoldx.2018.11.002. Epub 2018 Dec 18.
9
Mutant p53 as a guardian of the cancer cell.突变型 p53 作为癌细胞的守护者。
Cell Death Differ. 2019 Jan;26(2):199-212. doi: 10.1038/s41418-018-0246-9. Epub 2018 Dec 11.
10
Genome-Informed Targeted Therapy for Osteosarcoma.基于基因组信息的骨肉瘤靶向治疗。
Cancer Discov. 2019 Jan;9(1):46-63. doi: 10.1158/2159-8290.CD-17-1152. Epub 2018 Sep 28.